Business Services
Pharmaceutical Business Services – News, analysis and company profiles
Novartis announces cut to multiple drug research programmes in 2022 full-year report
February 2, 2023 Business Services
Novartis, a Swiss pharmaceutical company, has announced in its 2022 full-year report that it is cutting several of their programmes, …
Sherlock Biosciences acquires Sense Biodetection to advance CRISPR-based diagnostics
February 2, 2023 Business Services
US-based biotech company Sherlock Biosciences has acquired UK-based developer of rapid molecular diagnostics Sense Biodetection. The acquisition will integrate …
PureTech to Present at the SVB Securities Global Biopharma Conference
February 1, 2023 Business Services
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to changing the treatment …
Ellipses Pharma announces FDA approval of IND application for EP0042 for patients with acute myeloid leukaemia
February 1, 2023 Business Services
Ellipses Pharma (“Ellipses”), a global drug development company focused on accelerating the development of cancer medicines and treatments through an …
ViCentra bolsters leadership team with the appointment of Leo Toole as Chief Financial Officer and expands European commercialization
February 1, 2023 Business Services
February 1, Utrecht, The Netherlands ViCentra B.V., the company behind Kaleido, one of the world’s smallest, lightest and most …
Germo Gericke, MD
February 1, 2023 Business Services
Dr. Gericke brings extensive experience in the research and development of radioligand therapies Appointment coincides with launch of Ariceum International …
Sequana Medical announces grant of additional DSR® patent in United States
February 1, 2023 Business Services
Ghent, Belgium – 1 February 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medic
Neuraxpharm announces closing of acquisition of established products from Sanofi
February 1, 2023 Business Services
Düsseldorf and Barcelona – February 1, 2023 – Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the …
Dr Jean-Michel Cosséry
February 1, 2023 Business Services
Jean-Michel brings 25 years of experience in the international pharmaceutical and biotech industries both in an executive and non-executive capacity …
Rare and Orphan disease expert Terebellum to launch incisive Specialty Pharmacy development bulletins, Specialty Pharmaceutical Pulse™
January 31, 2023 Business Services
Global healthcare and business consulting services provider Terebellum is launching a brand-new monthly Specialty Pharmaceutical Pulse™ insights bulletin in the …
Dr. Lin Römer
January 31, 2023 Business Services
Munich, 31 January 2023 – Insempra, a biology-powered company enabling businesses to make superior products in partnership with nature, today …
Vertex and CRISPR Therapeutics Announce MHRA Marketing Authorisation Application Validation for CRISPR/Cas9 GeneEdited Therapy, exagamglogene autotemcel (exa-cel
January 30, 2023 Business Services
London, UK and ZUG, Switzerland, January 27, 2023 – Vertex Pharmaceuticals (Europe) and CRISPR Therapeutics (NASDAQ: CRSP) today announced that …
BEXIMCO PHARMACEUTICALS LIMITED Half Year Results 2022-23
January 30, 2023 Business Services
Beximco Pharmaceuticals Limited (“Beximco Pharma”, “BPL” or “the Company”; AIM Symbol: BXP, LEI No.: 213800IMBBD6TIOQGB56), the fast-growing manufacturer of generic …
Kelso Pharma announces first product launch
January 30, 2023 Business Services
30th January 2023: Kelso Pharma, the growing UK based specialty pharma business, has announced its first product launch with the …
Pharmacists say England is not yet unlocking potential of self-care, with 77% backing the idea of a National Self-Care Strategy
January 30, 2023 Business Services
London, 30 January 2023. Today, a new report by Sanofi, an innovative global healthcare company, calls on the Government to …
Latest content
Pharma sees climate disruption as growing supply-chain risk
September 11, 2026
Manchester NHS-MHRA partnership to test new technologies in real-world care
September 10, 2026
